Activity that aims to ensure that the benefits of a medicinal product exceed the risks by the greatest achievable margin, by increasing the benefits or reducing the risks in three stages:
- Characterization of the safety profile of the medicinal product
- Planning of pharmacovigilance activities to identify and characterize risks
- Risk minimization and mitigation, assessment of the effectiveness of these activities
